Thalidomide responsive chronic pulmonary GVHD

Bone Marrow Transplantation

Volumn 17, Issue 2, 1996, Pages 291-293

  Forsyth, C J ^a   Cremer, P D ^a   Torzillo, P ^a   Iland, H J ^a   Young, G A R ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Allogeneic BMT; Bronchiolitis obliterans; GVHD; Thalidomide

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; THALIDOMIDE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; LUNG DISEASE; LUNG FUNCTION; MALE; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADULT; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CYCLOSPORINE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MULTIPLE MYELOMA; THALIDOMIDE;

EID: 0030044279     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Urbanski SJ, Kossakowska AE, Curtis J et al. Idiopathic small airways pathology in patients with GVHD following allogeneic bone marrow transplantation. Am J Surg Pathol 1987; 11: 965-971.
2. Sullivan KM, Shulman HM. Chronic GVHD, obliterative bronchiolitis, and GVL effect: case histories. Transplant Proc 1989; 21: 51-62.
3. Clark JG, Crawford SW, Madtes DK. Sullivan KM. The clinical presentation and course of obstructive lung disease after allogeneic marrow transplantation. Ann Int Med 1989; 111: 368-376.
4. Vogelsang GB, Hess AD, Santos GW. Thalidomide for treatment of GVHD. Bone Marrow Transplant 1988; 3: 393-398.
5. Vogelsang GB, Hess AD, Gordon G, Santos GW. Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model. Transplantation 1986, 41: 644-647.
6. Vogelsang GB, Farmer ER, Hess AD et al. Thalidomide for the treatment of chronic graft-versus-host disease. New Engl J Med 1992: 326: 1055-1058.
7. Heney D, Norfolk DR, Wheeldon J et al. Thalidomide treatment for chronic GVHD. Br J Haematol 1991; 78: 23-27.
8. Saurat JH, Camenzind M. Helg C, Chapuis B. Thalidomide for GVHD after bone marrow transplantation. Lancer 1988; 1: 359.
9. McCarthy DM, Kanfer E, Taylor J, Barrett AJ. Thalidomide for GVHD. Lancer 1988; 2: 1135.
10. Lopez J. Ulibarrena C, Garcia-Larana J et al. Thalidomide as therapy for intestinal chronic GVHD. Bone Marrow Transplant 1993, 11: 251-252.
11. Ehninger G, Eger K, Stuhler A, Schuler U, Thalidomide - the need for a new clinical evaluation of an old drug. Bone Marrow Transplant 1993; 12 (Suppl. 3): S26-S28.
12. Ochonisky S, Verroust J, Bastuji-Garin S et al. Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients. Arch Dermatol 1994; 130: 66-69.
13. Powell RJ, Gardner-Medwin JMM. Guidelines for the clinical use and dispensing of thalidomide. Postgrad Med J 1994; 70: 901-904.